MedTrace Logo

Participation and Detection Rate of Screening CT Colonography and Screening Sigmoidoscopy

NCT01739608 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40945

Last updated 2020-01-31

No results posted yet for this study

Summary

The objectives of this multicenter, randomized trial is to assess the participation rate achievable through two different screening strategies (Computed Tomographic Colonography-CTC and sigmoidoscopy-FS), to compare detection rate of colorectal cancer (CRC) and advanced adenoma of tests and to evaluate their costs. The role of Computer-aided detection (CAD) for CTC screening will be also assessed. The trial involves 10 Italian centers located in the Piedmont Region and in Verona. Residents aged 58-60 years in those districts are target for recruitment. Exclusion criteria include: previous diagnosis of cancer or adenoma; family history or hereditary syndromes; personal history of inflammatory bowel disease; patients screened by colonoscopy or FOBT within 2 years; severe disease.

Conditions

Interventions

OTHER

Invitation to screening

Invitation to screening

Sponsors & Collaborators

  • im3D S.p.A.

    collaborator OTHER

  • Regione Piemonte

    collaborator OTHER

  • Candiolo Cancer Institute - IRCCS

    collaborator OTHER

  • Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

    lead OTHER

Principal Investigators

  • Daniele Regge, MD · Institute for Cancer Research and Treatment at Candiolo

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
58 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-12-31
Completion
2018-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739608 on ClinicalTrials.gov